8 Cheap Beginner Stocks to Buy Right Now
Talk of a slowing economy has once again gained popularity within economic circles.
Author Archive - Sheryar Siddiq
15 Best Stocks to Invest in for an 18 Year Old
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable...
UBS Reiterates Philip Morris Price Target Amid ZYN Supply Recovery
On June 4, UBS analysts reiterated their Neutral rating for Philip Morris International Inc. (NYSE:PM) while keeping the price target at $170.
Couchbase Gets Slight Boost as UBS Increases Price Target Despite Mixed Q1
On June 4, UBS analysts maintained a Neutral rating for Couchbase Inc. (NASDAQ:BASE) and raised their price target for the stock from $18 to $20.
Stifel Maintains Buy Rating on International Game Technology (IGT), Keeps PT
On June 4, Stifel analysts reaffirmed their $20 price target and Buy rating for International Game Technology PLC (NYSE:IGT).
Guggenheim Maintains Buy Rating on Neurocrine Biosciences Following Investor Meeting
On June 4, analysts at Guggenheim reiterated their Buy rating for Neurocrine Biosciences, Inc. (NASDAQ:NBIX), keeping their price target at $165.
AutoZone (AZO) Earns Bullish Endorsement from TD Cowen Despite Tariff Concerns
With a price target of $4,300, TD Cowen analysts reaffirmed their Buy rating on AutoZone Inc. (NYSE:AZO) stock on June 4.
Bernstein Analysts See Strategic Discipline Ahead Under New UnitedHealth CEO
With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth Group Incorporated (NYSE:UNH) on June 4.
Susquehanna Lifts CrowdStrike (CRWD) PT After Q1 Results
While maintaining a Positive rating, Susquehanna analysts raised their price target for CrowdStrike Holdings Inc. (NASDAQ:CRWD) from $425 to $530 on June 4.
CVS Health (CVS) Maintains Overweight Rating at Cantor Amid Membership Data Discrepancies
Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on June 4.
Pegasystems (PEGA) Price Target Raised on AI Product Momentum and Revenue Outlook
On June 4, Rosenblatt analysts maintained their Buy rating on Pegasystems Inc. (NASDAQ:PEGA) while raising their price target on the company's shares from $101 to $112.
Scotiabank Boosts Asana (ASAN) PT on Improved Margins, AI Studio Momentum
Scotiabank analysts maintained their Sector Perform rating on Asana Inc. (NYSE:ASAN) and increased their price target from $12 to $16.50 on June 4.
Axon Enterprise (AXON) Gets Price Target Hike on Strong Growth Outlook
On May 29, TD Cowen reiterated its bullish review of Axon Enterprise Inc. (NASDAQ:AXON), raising the price target from $750 to $800 while keeping the stock's rating at Buy.
KeyCorp Gets Steady Target From KBW Despite Slight Dip in Investment Banking Growth
With a stable price target of $18, analyst David Konrad of Keefe, Bruyette & Woods kept his Outperform rating on KeyCorp (NYSE:KEY) on May 29.
Citi Reiterates Buy on Knight-Swift (KNX), Raises Price Target Amid Freight Optimism
Ariel Rosa of Citi revised the firm's outlook on Knight-Swift Transportation Holdings Inc. (NYSE:KNX) on May 30.
Alcon Stock Rated Buy by BTIG Following TRYPTYR Approval
On May 30, BTIG analysts reaffirmed their Buy rating and $99 price target for Alcon Inc.
Sempra Price Target Lifted by Jefferies Despite Lowered Guidance
Julian Dumoulin-Smith, an analyst at Jefferies, revised his outlook for Sempra (NYSE:SRE), increasing the price target from $75 to $78 while keeping the stock at a Hold rating...
H.C. Wainwright Raises Purple Biotech (PPBT) Price Target, Reiterates Buy Rating
On May 30, Emily Bodnar, an analyst at H.C. Wainwright, raised her price target for Purple Biotech Ltd.
H.C. Wainwright Maintains Buy Rating on Sangamo Therapeutics (SGMO)
Sangamo Therapeutics, Inc.
Stifel Maintains Bullish Stance on Lululemon Amid Growth Expectations
On May 30, Stifel reiterated its Buy rating and $353 price target for Lululemon Athletica Inc. (NASDAQ:LULU).
Evercore Hikes Price Target on ZScaler (ZS) After ‘Across-the-Board’ Q3 Beat
Peter Levine, an analyst from Evercore ISI, raised his price target for Zscaler, Inc.
Benchmark Reaffirms Bullish Outlook on SunCoke Energy Amid Acquisition News
SunCoke Energy has announced the final agreement to pay $325 million, cash-free and debt-free, for Phoenix Global, a privately held service supplier to large steel producers.
Seacoast Banking Gets KBW Endorsement After Villages Bancorporation Acquisition
Keefe, Bruyette, and Woods reiterated their optimistic outlook on Seacoast Banking Corporation of Florida (NASDAQ:SBCF) on May 30, keeping their Outperform rating alongside a $...
Stellantis (STLA) Named Top EV Pick Amid U.S. Market Slowdown by Bernstein
Bernstein Daniel Roeska offered insights into the evolving electric vehicle market on May 30, emphasizing how the Western and Chinese sectors are taking different routes.
GLJ Research Downgrades U.S. Steel (X) to Sell, Cites Overvaluation in Nippon Deal
Gordon Johnson, an analyst at GLJ Research, downgraded United States Steel Corporation (NYSE:X) from Buy to Sell on May 30, pointing to possible overvaluation in the proposed...
Netflix (NFLX) Target Increased by Evercore Amid Expanding Market Potential
Evercore ISI analyst Mark Mahaney maintained his Outperform rating on May 30 while raising his price target for Netflix, Inc. (NASDAQ:NFLX) from $1,150 to $1,350.
Raymond James Maintains Outperform Rating on J.B. Hunt (JBHT), Keeps PT
Raymond James analyst Patrick Tyler Brown reiterated his Outperform rating and $155 price target for J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) on May 30.
KBW Maintains Bullish Outlook on NACCO Industries After Management Discussions
On May 30, Keefe, Bruyette & Woods reiterated their Outperform rating and $2,300 price target for NACCO Industries, Inc. (NYSE:NC) shares, indicating their continued optimism.
Citi Maintains Price Target for Brown-Forman (BF-B) Ahead of Q4 FY2025 Results
Citi maintained a $35 price target for Brown-Forman Corporation (BF-B) and reiterated its Neutral position on May 30.
Loop Capital Boosts Sea Ltd. Price Target Amid Strength in Shopee and Garena
Loop Capital Markets raised its price target for Sea Limited (NYSE:SE) from $165 to $190 on May 29 while maintaining a Buy rating on the company's shares.
BofA Lifts Pure Storage (PSTG) Target Price After Q1 FY26 Results
Wamsi Mohan of BofA Securities revised his rating outlook on Pure Storage, Inc.
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance
H.C. Wainwright reiterated its Buy rating and $28 price target for Olema Pharmaceuticals, Inc.
H.C. Wainwright Reiterates Buy on Halozyme (HALO), Maintains Price Target
H.C. Wainwright's Mitchell Kapoor maintained Halozyme Therapeutics Inc. (NASDAQ:HALO) at a $72 price target and a Buy rating on May 29.
RBC Reaffirms Outperform on Regeneron (REGN) Ahead of Key COPD Drug Results
Analyst Brian Abrahams reiterated an Outperform rating and a price target of $943 for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on May 29.
Performance Food Group Company (PFGC) Stock Rated Outperform by BMO Following Growth-Focused Analyst Day
Analysts at BMO Capital outlined the key observations from Performance Food Group's May 28 Analyst Day.
CrowdStrike Price Target Raised by UBS Amid Bullish Growth Outlook
With revenue expanding at a rate of 29.39% and earnings due in less than a week, Boyd does not see recent developments—like staff layoffs and the Carahsoft/IRS deal—to be ...
Capri Holdings (CPRI) Stock Target Cut by BofA After EPS Miss
BofA Securities lowered its price target for Capri Holdings Limited (NYSE:CPRI) from $23 to $21 on May 29 while maintaining its Neutral rating for the company's shares.
Taysha Gene Therapies (TSHA) Price Target Raised by JMP on Positive Rett Syndrome Trial Data
On May 29, JMP Securities Silvan Tuerkcan revised the firm's view on Taysha Gene Therapies, Inc.
Bernstein Maintains Outperform Rating on United Parcel Service (UPS) After CEO’s Strategy Talk
Bernstein analysts reiterated their Outperform rating and $133 price target for United Parcel Service, Inc.
Rhythm Pharmaceuticals (RYTM) Gets Price Target Upgrade by Stifel Amid Obesity Drug Optimism
On May 29, analysts at Stifel raised their price target for Rhythm Pharmaceuticals Inc.
Kyndryl Chosen by Virginia DMV for Major Cloud IT Overhaul
The Virginia Department of Motor Vehicles (DMV) and Kyndryl Holdings, Inc.
Weyerhaeuser Stock Rated Hold by Argus as Housing Sector Remains Weak
Argus analyst Marie Ferguson maintained a Hold rating on Weyerhaeuser Company (NYSE:WY) on May 28, citing the company's challenges in the current economic environment, with no...
Needham Sees Upside in Rocket Lab Post-Geost Deal, Hikes Price Target
Needham reaffirmed its Buy rating on Rocket Lab USA, Inc. (NASDAQ:RKLB) and increased its price target from $28 to $32 on May 28.
Jefferies Trims Sunrun Price Target Amid IRA Uncertainty
The change coincides with House debates over the Inflation Reduction Act (IRA) amendments and the expectation of additional leniency from the Senate.
Benchmark Maintains Buy Rating on Ooma, Cites AirDial as Key Growth Catalyst
On May 28, Benchmark analyst Matt Harrigan reaffirmed his stable Buy rating for Ooma Inc. (NYSE:OOMA) while maintaining a price target of $20.
William Blair Starts Centrus Energy With Outperform, Cites Nuclear Fuel Leadership
William Blair analyst Jed Dorsheimer initiated coverage of Centrus Energy Corp. (NYSE:LEU) on May 28 with an Outperform rating and no price target.
DA Davidson Lifts TripAdvisor Price Target After Strong Q1 Report
On May 28, DA Davidson updated its TripAdvisor Inc. (NASDAQ:TRIP) financial model, maintaining a Neutral rating but marginally raising the price target from $16 to $16.25.
Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone
Spero Therapeutics, Inc.
Piper Sandler Reiterates Overweight Rating on Colgate-Palmolive Amid Tariff Strategy
Piper Sandler reiterated its $109 price target and Overweight rating on Colgate-Palmolive Company (NYSE:CL) on May 28.
